Could gabapentin or oxcarbazepine ease chronic nerve pain in kids?

NCT ID NCT02219373

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two drugs, gabapentin and oxcarbazepine, for treating chronic nerve pain in children aged 8 to 18. Sixty participants will receive one drug or the other in a blinded fashion, with the option to switch if pain doesn't improve. The goal is to see which drug reduces pain more effectively and is better tolerated.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Gabapentin and Oxcarbazepine
What this could lead to
If successful, this trial could show that gabapentin or oxcarbazepine effectively reduces chronic nerve pain in children, offering a treatment option where few exist.
What could go wrong
This is a small, early-phase study with only 60 participants. It may not prove which drug works best, and side effects like drowsiness or headaches could limit use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMPLEX REGIONAL PAIN SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Boston Children's Hospital

    Boston, Massachusetts, 02115, United States

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.